0001752724-20-117831.txt : 20200615 0001752724-20-117831.hdr.sgml : 20200615 20200615120949 ACCESSION NUMBER: 0001752724-20-117831 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200430 FILED AS OF DATE: 20200615 PERIOD START: 20200731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LORD ABBETT DEVELOPING GROWTH FUND, INC. CENTRAL INDEX KEY: 0000276914 IRS NUMBER: 132958970 STATE OF INCORPORATION: MD FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-02871 FILM NUMBER: 20962426 BUSINESS ADDRESS: STREET 1: 90 HUDSON ST. CITY: JERSEY CITY STATE: NJ ZIP: 07302 BUSINESS PHONE: 201-827-2000 MAIL ADDRESS: STREET 1: 90 HUDSON ST. CITY: JERSEY CITY STATE: NJ ZIP: 07302 FORMER COMPANY: FORMER CONFORMED NAME: LORD ABBETT DEVELOPING GROWTH FUND INC /NEW/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DEVELOPING GROWTH SHARES INC DATE OF NAME CHANGE: 19600201 0000276914 S000006834 LORD ABBETT DEVELOPING GROWTH FUND INC C000018473 Class A LAGWX C000018475 Class C LADCX C000018476 Class P LADPX C000018477 Class I LADYX C000054855 Class F LADFX C000054856 Class R2 LADQX C000054857 Class R3 LADRX C000151972 Class R4 LADSX C000151973 Class R5 LADTX C000151974 Class R6 LADVX C000188220 Class F3 LOGWX NPORT-P 1 primary_doc.xml NPORT-P false 0000276914 XXXXXXXX S000006834 C000018475 C000054855 C000018477 C000188220 C000054856 C000151974 C000054857 C000151973 C000151972 C000018473 C000018476 LORD ABBETT DEVELOPING GROWTH FUND, INC. 811-02871 0000276914 549300HWJ2W28SDTJF85 90 HUDSON ST. JERSEY CITY 07302 201-827-2000 LORD ABBETT DEVELOPING GROWTH FUND INC S000006834 549300HWJ2W28SDTJF85 2020-07-31 2020-04-30 N 1826812217.36 49558188.21 1777254029.15 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N Nevro Corp 254900SH91I4BOYKUE38 Nevro Corp 64157F103 236577.00000000 NS USD 27830918.28000000 1.565950495738 Long EC CORP US N 1 N N N Appian Corp 529900NIARIFW7HGU386 Appian Corp 03782L101 264766.00000000 NS USD 12091863.22000000 0.680367748316 Long EC CORP US N 1 N N Boston Beer Co Inc/The 529900Q02MQ0DCQNRM58 Boston Beer Co Inc/The 100557107 42299.00000000 NS USD 19732906.49000000 1.110303094906 Long EC CORP US N 1 N N N Coupa Software Inc 549300Q95ICR2GFL2K37 Coupa Software Inc 22266L106 109531.00000000 NS USD 19287313.79000000 1.085231119111 Long EC CORP US N 1 N N N Freshpet Inc 549300S4ZK8ZQ6HNPN59 Freshpet Inc 358039105 332292.00000000 NS USD 25058139.72000000 1.409935738448 Long EC CORP US N 1 N N N Aerovironment Inc 529900PGHVI29YLZ6221 Aerovironment Inc 008073108 137516.00000000 NS USD 8286714.16000000 0.466265037191 Long EC CORP US N 1 N N N Natera Inc N/A Natera Inc 632307104 261338.00000000 NS USD 9679959.52000000 0.544658183986 Long EC CORP US N 1 N N N Turning Point Therapeutics Inc N/A Turning Point Therapeutics Inc 90041T108 253903.00000000 NS USD 13078543.53000000 0.735884871576 Long EC CORP US N 1 N N N Peloton Interactive Inc 5493002YS021166W0339 Peloton Interactive Inc 70614W100 417688.00000000 NS USD 13157172.00000000 0.740309026408 Long EC CORP US N 1 N N N Everbridge Inc 549300WCY0UMR64ATW81 Everbridge Inc 29978A104 265380.00000000 NS USD 29558024.40000000 1.663128844565 Long EC CORP US N 1 N N N NextCure Inc 549300Y5PR6RJR1STI24 NextCure Inc 65343E108 188891.00000000 NS USD 6123846.22000000 0.344567862531 Long EC CORP US N 1 N N N Repligen Corp 54930006QJ0T5AUO1E71 Repligen Corp 759916109 239994.00000000 NS USD 27875303.10000000 1.568447877613 Long EC CORP US N 1 N N N SolarEdge Technologies Inc 5493000K6Y58XXPDF853 SolarEdge Technologies Inc 83417M104 248823.00000000 NS USD 27766158.57000000 1.562306688553 Long EC CORP US N 1 N N N Silicon Laboratories Inc 4PRDF8Q9TDHRVZKZSZ47 Silicon Laboratories Inc 826919102 99440.00000000 NS USD 9667556.80000000 0.543960325391 Long EC CORP US N 1 N N N Deciphera Pharmaceuticals Inc 529900QR4WAPYY0CBF25 Deciphera Pharmaceuticals Inc 24344T101 202848.00000000 NS USD 11761127.04000000 0.661758355704 Long EC CORP US N 1 N N N LGI Homes Inc 549300W02B4WNV8CV109 LGI Homes Inc 50187T106 410097.00000000 NS USD 24843676.26000000 1.397868613744 Long EC CORP US N 1 N N N Five9 Inc 254900MXP6EWY0SFFR59 Five9 Inc 338307101 470562.00000000 NS USD 43606980.54000000 2.453615511613 Long EC CORP US N 1 N N N Enphase Energy Inc 5493008U7KIGMI59Z314 Enphase Energy Inc 29355A107 416088.00000000 NS USD 19485401.04000000 1.096376810540 Long EC CORP US N 1 N N N MKS Instruments Inc 549300KEQATBHAGVF505 MKS Instruments Inc 55306N104 239035.00000000 NS USD 23958478.05000000 1.348061540839 Long EC CORP US N 1 N N N Karuna Therapeutics Inc N/A Karuna Therapeutics Inc 48576A100 140762.00000000 NS USD 11694506.96000000 0.658009871869 Long EC CORP US N 1 N N N Generac Holdings Inc 529900S2H2AHJHSFFI84 Generac Holdings Inc 368736104 377815.00000000 NS USD 36814293.60000000 2.071414271465 Long EC CORP US N 1 N N N Inspire Medical Systems Inc 549300XQQCQ7HCJKTW25 Inspire Medical Systems Inc 457730109 350631.00000000 NS USD 25126217.46000000 1.413766239822 Long EC CORP US N 1 N N N Teladoc Health Inc 549300I2PVFBC9MFAC61 Teladoc Health Inc 87918A105 194682.00000000 NS USD 32042710.38000000 1.802933618629 Long EC CORP US N 1 N N N Trex Co Inc N/A Trex Co Inc 89531P105 208751.00000000 NS USD 19877270.22000000 1.118425947781 Long EC CORP US N 1 N N N Assetmark Financial Holdings Inc 5493001K4EDHT2T6W812 Assetmark Financial Holdings Inc 04546L106 714088.00000000 NS USD 17130971.12000000 0.963901099056 Long EC CORP US N 1 N N N Citibank NA E57ODZWZ7FF32TWEFA76 CITIBANK NA DDCA 000000000 2734912.00000000 NS USD 2734912.00000000 0.153884135590 Long STIV RF US N 1 N N Q2 Holdings Inc 549300M9RKR9DZXWS696 Q2 Holdings Inc 74736L109 180561.00000000 NS USD 14394322.92000000 0.809919273435 Long EC CORP US N 1 N N N Medallia Inc 5493009P6W6C5BK60J60 Medallia Inc 584021109 221972.00000000 NS USD 4767958.56000000 0.268276705625 Long EC CORP US N 1 N N N Strategic Education Inc 0PYXF82EO1UCNGL5I740 Strategic Education Inc 86272C103 145139.00000000 NS USD 23120642.70000000 1.300919413926 Long EC CORP US N 1 N N N Cirrus Logic Inc 549300NKSJEM5ZZSSV18 Cirrus Logic Inc 172755100 196042.00000000 NS USD 14820775.20000000 0.833914283322 Long EC CORP US N 1 N N N Carvana Co 5493003WEAK2PJ5WS063 Carvana Co 146869102 97029.00000000 NS USD 7772993.19000000 0.437359716872 Long EC CORP US N 1 N N SVMK Inc N/A SVMK Inc 78489X103 1853231.00000000 NS USD 29095726.70000000 1.637116935608 Long EC CORP US N 1 N N N Globant SA 2221008DCMSPYS42DS88 Globant SA 000000000 191157.00000000 NS USD 22111130.19000000 1.244117600936 Long EC CORP LU N 1 N N N Masimo Corp 549300Q4A8JK0PIYCU29 Masimo Corp 574795100 105374.00000000 NS USD 22540552.34000000 1.268279715240 Long EC CORP US N 1 N N N Arena Pharmaceuticals Inc 529900CVGQMPJ3A3NI85 Arena Pharmaceuticals Inc 040047607 200486.00000000 NS USD 9817799.42000000 0.552413963281 Long EC CORP US N 1 N N N ChemoCentryx Inc 529900YTTXUSFQTAKY40 ChemoCentryx Inc 16383L106 336977.00000000 NS USD 17863150.77000000 1.005098341430 Long EC CORP US N 1 N N N Paylocity Holding Corp 549300VH75FTB4DIEE07 Paylocity Holding Corp 70438V106 210626.00000000 NS USD 24122995.78000000 1.357318390299 Long EC CORP US N 1 N N N Semtech Corp 549300J7WUY317SW6O61 Semtech Corp 816850101 232562.00000000 NS USD 10521104.88000000 0.591986553831 Long EC CORP US N 1 N N N Wingstop Inc 549300SSH3F8HPIM3Q47 Wingstop Inc 974155103 257184.00000000 NS USD 30159967.68000000 1.696998132249 Long EC CORP US N 1 N N N Cardlytics Inc 549300JETJBH94EIPC66 Cardlytics Inc 14161W105 160838.00000000 NS USD 7229668.10000000 0.406788674068 Long EC CORP US N 1 N N N Iovance Biotherapeutics Inc 549300220Z2GHH33XL82 Iovance Biotherapeutics Inc 462260100 426560.00000000 NS USD 13713904.00000000 0.771634430141 Long EC CORP US N 1 N N N Federal Signal Corp 549300RTXZRPTNP6G884 Federal Signal Corp 313855108 814600.00000000 NS USD 21937178.00000000 1.234329906709 Long EC CORP US N 1 N N N iRhythm Technologies Inc 549300FJI72RJGDQS384 iRhythm Technologies Inc 450056106 165744.00000000 NS USD 17509196.16000000 0.985182527248 Long EC CORP US N 1 N N N Monolithic Power Systems Inc 529900TB7O85LSZ1XU31 Monolithic Power Systems Inc 609839105 190693.00000000 NS USD 38121437.63000000 2.144962791179 Long EC CORP US N 1 N N N Deckers Outdoor Corp 5493008LG4W3I6K8J118 Deckers Outdoor Corp 243537107 80460.00000000 NS USD 11969229.60000000 0.673467574341 Long EC CORP US N 1 N N N Immunomedics Inc 5493007ZU7DDO8PSIM59 Immunomedics Inc 452907108 792181.00000000 NS USD 24066458.78000000 1.354137246857 Long EC CORP US N 1 N N N FTI Consulting Inc 549300K17GM8EQD0FQ48 FTI Consulting Inc 302941109 152486.00000000 NS USD 19420616.96000000 1.092731632139 Long EC CORP US N 1 N N N Blueprint Medicines Corp 5299004CC60O9T5HVM83 Blueprint Medicines Corp 09627Y109 211840.00000000 NS USD 12462547.20000000 0.701224866878 Long EC CORP US N 1 N N N Tetra Tech Inc 549300UJ1LP7JGJC5P32 Tetra Tech Inc 88162G103 242352.00000000 NS USD 18244258.56000000 1.026541972096 Long EC CORP US N 1 N N N Bright Horizons Family Solutions Inc N/A Bright Horizons Family Solutions Inc 109194100 101123.00000000 NS USD 11775773.35000000 0.662582453428 Long EC CORP US N 1 N N N Fidelity Investments 549300FQDFZGLUOCWN51 Fidelity Investments Money Market Government Portfolio 31607A703 24614204.00000000 NS USD 24614204.00000000 1.384956995245 Long STIV RF US N 1 N N MasTec Inc 549300TMDIT8WREDOF45 MasTec Inc 576323109 251303.00000000 NS USD 9021777.70000000 0.507624546183 Long EC CORP US N 1 N N N uniQure NV N/A uniQure NV 000000000 145244.00000000 NS USD 9243328.16000000 0.520090432115 Long EC CORP NL N 1 N N N Avalara Inc N/A Avalara Inc 05338G106 312403.00000000 NS USD 27919456.11000000 1.570932216333 Long EC CORP US N 1 N N N Novanta Inc N/A Novanta Inc 67000B104 118756.00000000 NS USD 10318708.84000000 0.580598421539 Long EC CORP CA N 1 N N N Etsy Inc 54930089Q7XT501AEA40 Etsy Inc 29786A106 202921.00000000 NS USD 13163485.27000000 0.740664252498 Long EC CORP US N 1 N N N Redfin Corp 549300HXWD3JEMZU3O57 Redfin Corp 75737F108 1248896.00000000 NS USD 26389172.48000000 1.484828395219 Long EC CORP US N 1 N N N National Vision Holdings Inc 549300JHURCBLI5ROA42 National Vision Holdings Inc 63845R107 551003.00000000 NS USD 14601579.50000000 0.821580891673 Long EC CORP US N 1 N N N HubSpot Inc 529900BLNVEW0MVKJB37 HubSpot Inc 443573100 62624.00000000 NS USD 10560285.12000000 0.594191091807 Long EC CORP US N 1 N N N Endava PLC 213800JJ6CRPCWCQVZ25 Endava PLC 29260V105 313915.00000000 NS USD 13740059.55000000 0.773106113399 Long EC CORP GB N 1 N N N YETI Holdings Inc 549300DSQICIGNT5GO63 YETI Holdings Inc 98585X104 1058062.00000000 NS USD 29213091.82000000 1.643720669125 Long EC CORP US N 1 N N N Goosehead Insurance Inc 549300WH5MBIWHJ9XY95 Goosehead Insurance Inc 38267D109 307490.00000000 NS USD 17262488.60000000 0.971301137421 Long EC CORP US N 1 N N N Mirati Therapeutics Inc 529900GYRW59IDQV6N54 Mirati Therapeutics Inc 60468T105 255313.00000000 NS USD 21711817.52000000 1.221649643995 Long EC CORP US N 1 N N N Blackline Inc 529900P9N7PK9LV5EK56 Blackline Inc 09239B109 229502.00000000 NS USD 13939951.48000000 0.784353347994 Long EC CORP US N 1 N N N Coherus Biosciences Inc 5493007IL8W5MV932D26 Coherus Biosciences Inc 19249H103 501833.00000000 NS USD 8330427.80000000 0.468724654065 Long EC CORP US N 1 N N N Myovant Sciences Ltd N/A Myovant Sciences Ltd 000000000 582474.00000000 NS USD 6978038.52000000 0.392630339025 Long EC CORP BM N 1 N N N Malibu Boats Inc N/A Malibu Boats Inc 56117J100 429185.00000000 NS USD 14755380.30000000 0.830234736170 Long EC CORP US N 1 N N N Sarepta Therapeutics Inc 549300IKDPIED8J8IG21 Sarepta Therapeutics Inc 803607100 144444.00000000 NS USD 17027058.72000000 0.958054304040 Long EC CORP US N 1 N N N Lyft Inc 549300H7I5VN334XVZ52 Lyft Inc 55087P104 249580.00000000 NS USD 8193711.40000000 0.461032090270 Long EC CORP US N 1 N N N Axonics Modulation Technologies Inc 549300LJY4X7N57VJL05 Axonics Modulation Technologies Inc 05465P101 354106.00000000 NS USD 11405754.26000000 0.641762745951 Long EC CORP US N 1 N N FIXED INC CLEARING CORP.REPO 549300H47WTHXPU08X20 FIXED INC CLEARING CORP.REPO 000000000 59565769.07000000 PA USD 59565769.07000000 3.351561909159 Long RA CORP US N 2 Repurchase N 0.00000000 2020-05-01 57630000.00000000 USD 60761210.79000000 USD UST N N N Qualys Inc 549300EMBXYOW9W1XA17 Qualys Inc 74758T303 75135.00000000 NS USD 7922234.40000000 0.445757008849 Long EC CORP US N 1 N N N Chegg Inc 549300AKX7O8JG0O3G77 Chegg Inc 163092109 829280.00000000 NS USD 35451720.00000000 1.994746919603 Long EC CORP US N 1 N N N Penumbra Inc 549300RGE06P3ECANU72 Penumbra Inc 70975L107 118538.00000000 NS USD 21019158.16000000 1.182676073045 Long EC CORP US N 1 N N N GW Pharmaceuticals PLC 213800ISBN5CNUZMHZ39 GW Pharmaceuticals PLC 36197T103 88537.00000000 NS USD 8866095.18000000 0.498864823743 Long EC CORP GB N 1 N N Universal Display Corp N/A Universal Display Corp 91347P105 82534.00000000 NS USD 12390004.08000000 0.697143113858 Long EC CORP US N 1 N N N Evoqua Water Technologies Corp 529900YQAOMEZRGRRP43 Evoqua Water Technologies Corp 30057T105 1113342.00000000 NS USD 17869139.10000000 1.005435284259 Long EC CORP US N 1 N N N Inphi Corp 549300DCMERAAZFGT726 Inphi Corp 45772F107 490013.00000000 NS USD 47305855.02000000 2.661738515941 Long EC CORP US N 1 N N N 10X Genomics Inc 5493003Z6741WNLG7H43 10X Genomics Inc 88025U109 236945.00000000 NS USD 18924797.15000000 1.064833548811 Long EC CORP US N 1 N N N Helen of Troy Ltd N/A Helen of Troy Ltd 000000000 128097.00000000 NS USD 21043775.16000000 1.184061187362 Long EC CORP BM N 1 N N N eHealth Inc 5299003O8Y5OKXUZQ421 eHealth Inc 28238P109 73178.00000000 NS USD 7808092.60000000 0.439334640514 Long EC CORP US N 1 N N N Alteryx Inc 549300XWZG0JHL7I0827 Alteryx Inc 02156B103 171732.00000000 NS USD 19436627.76000000 1.093632505044 Long EC CORP US N 1 N N N Insulet Corp 549300TZTYD2PYN92D43 Insulet Corp 45784P101 121935.00000000 NS USD 24352858.20000000 1.370251961766 Long EC CORP US N 1 N N N Acceleron Pharma Inc 529900TQRID2UY164805 Acceleron Pharma Inc 00434H108 183150.00000000 NS USD 16580569.50000000 0.932931884134 Long EC CORP US N 1 N N N Argenx SE 7245009C5FZE6G9ODQ71 Argenx SE 04016X101 105939.00000000 NS USD 15519004.11000000 0.873201233783 Long EC CORP NL N 1 N N N Guardant Health Inc N/A Guardant Health Inc 40131M109 208783.00000000 NS USD 16067939.68000000 0.904087959090 Long EC CORP US N 1 N N N Grocery Outlet Holding Corp N/A Grocery Outlet Holding Corp 39874R101 392711.00000000 NS USD 13065494.97000000 0.735150673775 Long EC CORP US N 1 N N N Western Alliance Bancorp 5493003VJXZ5JXT9S762 Western Alliance Bancorp 957638109 248484.00000000 NS USD 8915605.92000000 0.501650623589 Long EC CORP US N 1 N N N Axon Enterprise Inc 549300QP2IEEGFE16681 Axon Enterprise Inc 05464C101 339098.00000000 NS USD 24655815.58000000 1.387298336400 Long EC CORP US N 1 N N N Dunkin' Brands Group Inc 549300311IRV47UCTO62 Dunkin' Brands Group Inc 265504100 133219.00000000 NS USD 8371481.96000000 0.471034631104 Long EC CORP US N 1 N N N Planet Fitness Inc 549300LLE5HUPF6H8G33 Planet Fitness Inc 72703H101 174084.00000000 NS USD 10502487.72000000 0.590939029972 Long EC CORP US N 1 N N N Quanta Services Inc SHVRXXEACT60MMH07S24 Quanta Services Inc 74762E102 356580.00000000 NS USD 12965248.80000000 0.729510164970 Long EC CORP US N 1 N N N Lumentum Holdings Inc 549300JLWRRC38DWEF52 Lumentum Holdings Inc 55024U109 328735.00000000 NS USD 26597948.85000000 1.496575526837 Long EC CORP US N 1 N N N Rocket Pharmaceuticals Inc 549300R7VV82YUIN4Y93 Rocket Pharmaceuticals Inc 77313F106 619006.00000000 NS USD 9161288.80000000 0.515474358180 Long EC CORP US N 1 N N N PTC Therapeutics Inc 549300UJLWOIWFDGB318 PTC Therapeutics Inc 69366J200 178985.00000000 NS USD 9113916.20000000 0.512808864153 Long EC CORP US N 1 N N N Limelight Networks Inc 529900BNCMDQGEKW5M59 Limelight Networks Inc 53261M104 2398395.00000000 NS USD 12159862.65000000 0.684193843454 Long EC CORP US N 1 N N N XPO Logistics Inc 54930096DB9LCLPN7H13 XPO Logistics Inc 983793100 212418.00000000 NS USD 14176777.32000000 0.797678727265 Long EC CORP US N 1 N N N CRISPR Therapeutics AG 506700O6IRRIQLT3W370 CRISPR Therapeutics AG 000000000 212180.00000000 NS USD 10439256.00000000 0.587381197554 Long EC CORP CH N 1 N N N Bridgebio Pharma Inc 54930028YG89VTY2J114 Bridgebio Pharma Inc 10806X102 704766.00000000 NS USD 21516505.98000000 1.210660132265 Long EC CORP US N 1 N N N ZYMEWORKS INC 894500AHOYAGYLYZJL67 Zymeworks Inc 98985W102 228285.00000000 NS USD 8339251.05000000 0.469221108137 Long EC CORP CA N 1 N N N 2020-05-28 LORD ABBETT DEVELOPING GROWTH FUND, INC. Vito Fronda Vito Fronda Treasurer XXXX NPORT-EX 2 NPORT_7559647263929279.htm

Schedule of Investments (unaudited)

LORD ABBETT DEVELOPING GROWTH FUND, INC. April 30, 2020

 

Investments  Shares   Fair
Value
(000)
 
COMMON STOCKS 96.09%          
           
Aerospace & Defense 1.85%          
           
AeroVironment, Inc.*   137,516   $8,287 
Axon Enterprise, Inc.*   339,098    24,656 
Total        32,943 
           
Air Freight & Logistics 0.80%          
           
XPO Logistics, Inc.*   212,418    14,177 
           
Banks 0.50%          
           
Western Alliance Bancorp   248,484    8,916 
           
Beverages 1.11%          
           
Boston Beer Co., Inc. (The) Class A*   42,299    19,733 
           
Biotechnology 15.67%          
           
Acceleron Pharma, Inc.*   183,150    16,581 
Arena Pharmaceuticals, Inc.*   200,486    9,818 
Argenx SE ADR*   105,939    15,519 
Blueprint Medicines Corp.*   211,840    12,463 
Bridgebio Pharma, Inc.*   704,766    21,516 
ChemoCentryx, Inc.*   336,977    17,863 
Coherus Biosciences, Inc.*   501,833    8,330 
CRISPR Therapeutics AG (Switzerland)*(a)   212,180    10,439 
Deciphera Pharmaceuticals, Inc.*   221,355    12,834 
Immunomedics, Inc.*   792,181    24,066 
Iovance Biotherapeutics, Inc.*   426,560    13,714 
Karuna Therapeutics, Inc.*   140,762    11,695 
Mirati Therapeutics, Inc.*   255,313    21,712 
Myovant Sciences Ltd. (United Kingdom)*(a)   582,474    6,978 
Natera, Inc.*   261,338    9,680 
PTC Therapeutics, Inc.*   178,985    9,114 
Rocket Pharmaceuticals, Inc.*   619,006    9,161 
Sarepta Therapeutics, Inc.*   144,444    17,027 
Turning Point Therapeutics, Inc.*   253,903    13,079 

 

See Notes to Schedule of Investments.

 

Schedule of Investments (unaudited)(continued)

LORD ABBETT DEVELOPING GROWTH FUND, INC. April 30, 2020

 

Investments  Shares   Fair
Value
(000)
 
Biotechnology (continued)          
           
uniQure NV (Netherlands)*(a)   145,244   $9,243 
Zymeworks, Inc. (Canada)*(a)   228,285    8,339 
Total        279,171 
           
Building Products 1.12%          
           
Trex Co., Inc.*   208,751    19,877 
           
Capital Markets 0.96%          
           
Assetmark Financial Holdings, Inc.*   714,088    17,131 
           
Commercial Services & Supplies 1.02%          
           
Tetra Tech, Inc.   242,352    18,244 
           
Communications Equipment 1.49%          
           
Lumentum Holdings, Inc.*   328,735    26,598 
           
Construction & Engineering 1.23%          
           
MasTec, Inc.*   251,303    9,022 
Quanta Services, Inc.   356,580    12,965 
Total        21,987 
           
Diversified Consumer Services 3.95%          
           
Bright Horizons Family Solutions, Inc.*   101,123    11,776 
Chegg, Inc.*   829,280    35,452 
Strategic Education, Inc.   145,139    23,120 
Total        70,348 
           
Electric-Generation 1.56%          
           
SolarEdge Technologies, Inc. (Israel)*(a)   248,823    27,766 
           
Electrical Equipment 2.07%          
           
Generac Holdings, Inc.*   377,815    36,814 

 

See Notes to Schedule of Investments.

 

Schedule of Investments (unaudited)(continued)

LORD ABBETT DEVELOPING GROWTH FUND, INC. April 30, 2020

 

Investments  Shares   Fair
Value
(000)
 
Electronic Equipment, Instruments & Components 0.53%          
           
Novanta, Inc.*   107,679   $9,356 
           
Electronics 2.66%          
           
Inphi Corp.*   490,013    47,306 
           
Food & Staples Retailing 0.73%          
           
Grocery Outlet Holding Corp.*   392,711    13,065 
           
Food Products 1.41%          
           
Freshpet, Inc.*   332,292    25,058 
           
Health Care Equipment & Supplies 6.98%          
           
Axonics Modulation Technologies, Inc.*(b)   354,106    11,406 
Insulet Corp.*   121,935    24,353 
iRhythm Technologies, Inc.*   165,744    17,509 
Masimo Corp.*   103,696    22,181 
Nevro Corp.*   236,577    27,831 
Penumbra, Inc.*   118,538    21,019 
Total        124,299 
           
Health Care Providers & Services 0.90%          
           
Guardant Health, Inc.*   208,783    16,068 
           
Health Care Technology 3.21%          
           
Inspire Medical Systems, Inc.*   350,631    25,126 
Teladoc Health, Inc.*   194,682    32,043 
Total        57,169 
           
Hotels, Restaurants & Leisure 2.75%          
           
Dunkin’ Brands Group, Inc.   133,219    8,371 
Planet Fitness, Inc. Class A*   174,084    10,503 
Wingstop, Inc.   257,184    30,160 
Total        49,034 

 

See Notes to Schedule of Investments.

 

Schedule of Investments (unaudited)(continued)

LORD ABBETT DEVELOPING GROWTH FUND, INC. April 30, 2020

 

Investments  Shares   Fair
Value
(000)
 
Household Durables 2.58%          
           
Helen of Troy Ltd.*   128,097   $21,044 
LGI Homes, Inc.*   410,097    24,843 
Total        45,887 
           
Information Technology Services 1.50%          
           
Endava plc ADR*   313,915    13,740 
Limelight Networks, Inc.*   2,546,714    12,912 
Total        26,652 
           
Insurance 1.47%          
           
eHealth, Inc.*   73,178    7,808 
Goosehead Insurance, Inc. Class A*   326,604    18,336 
Total        26,144 
           
Internet Software & Services 0.41%          
           
Cardlytics, Inc.*   160,838    7,230 
           
Leisure Products 3.21%          
           
Malibu Boats, Inc. Class A*   429,185    14,756 
Peloton Interactive, Inc. Class A*   417,688    13,157 
YETI Holdings, Inc.*   1,058,062    29,213 
Total        57,126 
           
Life Sciences Tools & Services 2.63%          
           
10X Genomics, Inc. Class A*   236,945    18,925 
Repligen Corp.*   239,994    27,875 
Total        46,800 
           
Machinery 2.23%          
           
Evoqua Water Technologies Corp.*   1,113,342    17,869 
Federal Signal Corp.   814,600    21,937 
Total        39,806 
           
Pharmaceuticals 0.84%          
           
GW Pharmaceuticals plc ADR*(b)   88,537    8,866 
NextCure, Inc.*   188,891    6,124 
Total        14,990 

 

See Notes to Schedule of Investments.

 

Schedule of Investments (unaudited)(continued)

LORD ABBETT DEVELOPING GROWTH FUND, INC. April 30, 2020

 

Investments  Shares   Fair
Value
(000)
 
Professional Services 1.09%          
           
FTI Consulting, Inc.*   152,486   $19,421 
           
Real Estate Management & Development 1.48%          
           
Redfin Corp.*   1,248,896    26,389 
           
Road & Rail 0.46%          
           
Lyft, Inc. Class A*   249,580    8,194 
           
Semiconductors & Semiconductor Equipment 7.42%          
           
Cirrus Logic, Inc.*   239,518    18,108 
Enphase Energy, Inc.*   416,088    19,485 
MKS Instruments, Inc.   239,035    23,959 
Monolithic Power Systems, Inc.   190,693    38,121 
Semtech Corp.*   232,562    10,521 
Silicon Laboratories, Inc.*   99,440    9,668 
Universal Display Corp.   82,534    12,390 
Total        132,252 
           
Software 15.61%          
           
Alteryx, Inc. Class A*   171,732    19,437 
Appian Corp.*(b)   264,766    12,092 
Avalara, Inc.*   312,403    27,920 
Blackline, Inc.*   229,502    13,940 
Coupa Software, Inc.*   109,531    19,287 
Everbridge, Inc.*   265,380    29,558 
Five9, Inc.*   470,562    43,607 
Globant SA (Argentina)*(a)   191,157    22,111 
HubSpot, Inc.*   62,624    10,560 
Medallia, Inc.*   187,907    4,036 
Paylocity Holding Corp.*   210,626    24,123 
Q2 Holdings, Inc.*   180,561    14,394 
Qualys, Inc.*   75,135    7,922 
SVMK, Inc.*   1,853,231    29,096 
Total        278,083 
           
Specialty Retail 1.99%          
           
Carvana Co.*(b)   97,029    7,773 
Etsy, Inc.*   202,921    13,163 

 

See Notes to Schedule of Investments.

 

Schedule of Investments (unaudited)(continued)

LORD ABBETT DEVELOPING GROWTH FUND, INC. April 30, 2020

 

Investments  Shares   Fair
Value
(000)
 
Specialty Retail (continued)          
           
National Vision Holdings, Inc.*   551,003   $14,602 
Total        35,538 
           
Textiles, Apparel & Luxury Goods 0.67%          
           
Deckers Outdoor Corp.*   80,460    11,969 
Total Common Stocks
(cost $1,353,002,727)
        1,711,541 
           
   Principal
Amount
(000)
      
SHORT-TERM INVESTMENTS 4.88%          
           
Repurchase Agreement 3.34%          
           
Repurchase Agreement dated 4/30/2020, 0.00% due 5/1/2020 with Fixed Income Clearing Corp. collateralized by $ 57,630,000 of U.S. Treasury Note at 2.875% due 11/15/2021; value: $60,761,211; proceeds: $59,565,769
(cost $59,565,769)
  $59,566    59,566 
           
   Shares
(000)
      
Money Market Funds 1.54%          
           
Fidelity Government Portfolio(c)   24,614    24,614 
CitiBank N.A.(c)   2,735    2,735 
Total Money Market Funds
(cost $27,349,116)
        27,349 
           
Total Short-Term Investments
(cost $86,914,885)
        86,915 
           
Total Investments in Securities 100.97%
(cost $1,439,917,612)
        1,798,456 
           
Liabilities in Excess of Securities Lending and Other Assets (0.97)%        (17,194)
Net Assets 100.00%       $1,781,262 

 

 
ADR American Depositary Receipt.
* Non-income producing security.
(a) Foreign security traded in U.S. dollars.
(b) All or a portion of these securities are temporarily on loan to unaffiliated broker/dealers.
(c) Security was purchased with the cash collateral from loaned securities.

 

See Notes to Schedule of Investments.

 

Schedule of Investments (unaudited)(concluded)

LORD ABBETT DEVELOPING GROWTH FUND, INC. April 30, 2020

 

The following is a summary of the inputs used as of April 30, 2020 in valuing the Fund’s investments carried at fair value(1):

 

Investment Type(2)  Level 1
(000)
   Level 2
(000)
   Level 3
(000)
   Total
(000)
 
Common Stocks  $1,711,541   $   $   $1,711,541 
Short-Term Investments                    
Repurchase Agreement       59,566        59,566 
Money Market  Funds   27,349            27,349 
Total  $1,738,890   $59,566   $   $1,798,456 

 

 
(1) Refer to Note 2(b) for a description of fair value measurements and the three-tier hierarchy of inputs.
(2) See Schedule of Investments for fair values in each industry and identification of foreign issuers and/or geography.

 

See Notes to Schedule of Investments.

 

1. ORGANIZATION

 

Lord Abbett Developing Growth Fund, Inc. (the “Fund”) is registered under the Investment Company Act of 1940, as amended (the “Act”), as a diversified, open-end management investment company. The Fund was incorporated under Maryland law on August 21, 1978. The Fund’s predecessor corporation was organized on July 11, 1973.

 

2. SIGNIFICANT ACCOUNTING POLICIES

 

(a)Investment Valuation-Under procedures approved by the Fund’s Board of Directors (the “Board”), Lord, Abbett & Co. LLC (“Lord Abbett”), the Fund’s investment manager, has formed a Pricing Committee to administer the pricing and valuation of portfolio investments and to ensure that prices utilized reasonably reflect fair value. Among other things, these procedures allow the Fund to utilize independent pricing services, quotations from securities and financial instrument dealers and other market sources to determine fair value.

 

Securities actively traded on any recognized U.S. or non-U.S. exchange or on The NASDAQ Stock Market LLC are valued at the last sale price or official closing price on the exchange or system on which they are principally traded. Events occurring after the close of trading on non-U.S. exchanges may result in adjustments to the valuation of foreign securities to reflect their fair value as of the close of regular trading on the New York Stock Exchange. The Fund may utilize an independent fair valuation service in adjusting the valuations of foreign securities. Unlisted equity securities are valued at the last quoted sale price or, if no sale price is available, at the mean between the most recently quoted bid and asked prices.

 

Securities for which prices are not readily available are valued at fair value as determined by the Pricing Committee. The Pricing Committee considers a number of factors, including observable and unobservable inputs, when arriving at fair value. The Pricing Committee may use related or comparable assets or liabilities, recent transactions, market multiples, book values and other relevant information to determine the fair value of portfolio investments. The Board or a designated committee thereof regularly reviews fair value determinations made by the Pricing Committee and may employ techniques such as reviewing related market activity, reviewing inputs and assumptions, and retrospectively comparing prices of subsequent purchases and sales transactions to fair value determinations made by the Pricing Committee.

 

Short-term securities with 60 days or less remaining to maturity are valued using the amortized cost method, which approximates fair value.

 

(b)Fair Value Measurements-Fair value is defined as the price that the Fund would receive upon selling an investment or transferring a liability in an orderly transaction to an independent buyer in the principal or most advantageous market of the investment. A three-tier hierarchy is used to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk - for example, the risk inherent in a particular valuation technique used to measure fair value (such as a pricing model) and/or the risk inherent in the inputs to the valuation technique. Inputs may be observable or unobservable. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability. Observable inputs are based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability. Unobservable inputs are based on the best information available in the circumstances. The three-tier hierarchy classification is determined based on the lowest level of inputs that is significant to the fair value measurement, and is summarized in the three broad Levels listed below:

 

  · Level 1 - unadjusted quoted prices in active markets for identical investments;
  · Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.); and
  · Level 3 - significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments).

 

A summary of inputs used in valuing the Fund’s investments as of April 30, 2020 and, if applicable, Level 3 rollforwards for the period then ended is included in the Fund’s Schedule of Investments.

 

Changes in valuation techniques may result in transfers into or out of an assigned level within the three-tier hierarchy. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

 

3. FEDERAL TAX INFORMATION

 

It is the policy of the Fund to meet the requirements of Subchapter M of the Internal Revenue Code applicable to regulated investment companies and to distribute substantially all taxable income and capital gains to its shareholders. Therefore, no income tax provision is required.

 

The Fund files U.S. federal and various state and local tax returns. No income tax returns are currently under examination. The statute of limitations on the Fund’s filed U.S. federal tax returns remains open generally three years after the filing of the tax return. The statutes of limitations on the Fund’s, state and local tax returns may remain open for an additional year depending upon the jurisdiction.

 

4. SECURITIES LENDING AGREEMENT

 

The Fund has established a securities lending agreement with Citibank, N.A. for the lending of securities to qualified brokers in exchange for securities or cash collateral equal to at least the market value of securities loaned, plus interest, if applicable. Cash collateral is invested in an approved money market fund. In accordance with the Fund’s securities lending agreement, the market value of securities on loan is determined each day at the close of business and any additional collateral required to cover the value of securities on loan is delivered to the Fund on the next business day. As with other extensions of credit, the Fund may experience a delay in the recovery of their securities or incur a loss should the borrower of the securities breach its agreement with the Fund or become insolvent at a time when the collateral is insufficient to cover the cost of repurchasing securities on loan.

 

As of April 30, 2020, the market value of securities loaned and collateral received for the Fund was as follows:

 

Market Value of Securities Loaned   Collateral Received
$27,349,116   $25,831,627